NCT00006351View on ClinicalTrials.gov

SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

December 31, 2001

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

lonafarnib

Trial Locations (1)

6500

University Medical Center Nijmegen, Nijmegen

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00006351 - SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract | Biotech Hunter | Biotech Hunter